Effectiveness and safety of upadacitinib in patients with moderate-to-severe atopic dermatitis and prior inefficacy of T helper 2 biologics: a propensity score-matched study.
Barei F, Chiei-Gallo A, Narcisi A, Ingurgio RC, Malagoli P, Girolomoni G, Maurelli M, Pezzolo E, Sciarrone C, Gola M, Magliulo M, Savoia P, Esposto E, Burroni AG, Amoruso F, Bianchi VG, Mercuri SR, Satolli F, De Felici Del Giudice MB, Pella P, Pinto R, Avallone G, Gurioli C, Piraccini BM, Balato A, Di Brizzi EV, Angileri RG, Margiotta FM, Romanelli M, Rossi M, Guanti MB, Lauletta G, Dastoli S, Patruno C, Napolitano M, Ortoncelli M, Ribero S, Marzano AV, Ferrucci SM.
Barei F, et al. Among authors: magliulo m.
Clin Exp Dermatol. 2025 Oct 27;50(11):2153-2162. doi: 10.1093/ced/llaf253.
Clin Exp Dermatol. 2025.
PMID: 40498636